Jefferies Raises Revenue, EPS Estimates for Agilent

The Jefferies analyst also elevated the target share price for Agilent on expectations of healthy organic revenues and "immaterial" effects from the Japanese earthquake and tsunami on Agilent's business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.